Dr. David Sternberg is a board-certified surgeon, thoracic surgeon, and cardiothoracic surgeon who treats patients at the Karmanos Cancer Institute in Michigan. Dr. Steinberg specializes in minimally invasive chest surgery and serves on the facility’s tumor board. His particular areas of clinical interest include lung cancer, esophageal cancer, and lung nodules, and he is skilled
Dr. Frank Baciewicz, Jr., is a thoracic and cardiothoracic surgeon at the Karmanos Cancer Institute in Detroit, Michigan, where he is part of the Multidisciplinary Team of the Thoracic Oncology Program. He treats patients diagnosed with lung cancer and esophageal cancer. His special clinical interests include minimally invasive robotic lung surgery, thoracoabdominal aneurysm surgery, ascending
Dr. Dipesh Uprety is an oncologist and hematologist at the University of Maryland Greenebaum Comprehensive Cancer Center. He specializes in thoracic oncology, focusing on patients with lung cancer, pleural mesothelioma, and other advanced thoracic cancers. Education and Career Dr. Uprety began his medical education in Dharan, Nepal, at the BP Koirala Institute of Health Sciences,
Dr. Tarik Hadid is a medical oncologist and hematologist who specializes in head and neck cancers and thoracic cancers. As a member of the Karmanos Cancer Institute’s Thoracic Oncology Program’s Multidisciplinary Team, he collaborates with other specialists to treat esophageal cancer, malignant pleural mesothelioma, lung cancer, and thymoma and thymic malignancies. Education and Career Dr.
Dr. Hirva Mamdani is a thoracic medical oncologist who specializes in the diagnosis and treatment of patients with malignant pleural mesothelioma, esophageal cancer, lung cancer, and other thoracic malignancies. She is the head of the Thoracic Oncology Multidisciplinary Team at Karmanos Cancer Institute in Detroit and is the Director of Lung Cancer Screening there. Education and
Dr. Scott J. Swanson is an accomplished general and thoracic surgeon at the Dana-Farber Cancer Institute and Brigham & Women’s Hospital in Boston. He is the Director of Brigham & Women’s Minimally Invasive Thoracic Surgery Program at Brigham and Women’s Hospital and serves as the Associate Chief of Surgery for Surgical Oncology at Dana-Farber. Education
Dr. David J. Kwiatkowski is a thoracic oncologist and genetic researcher with expertise in all types of thoracic malignancies. His particular interests include therapeutic targeting and personalized medicine approaches to cancer patient care. He is also a visiting scientist at the Broad Institute, where he is engaged in many cancer genome sequencing projects, including The Cancer
Dr. Pasi A. Jänne is a leading researcher and clinician in medical oncology and lung cancer. He was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations. He has played an integral role in the development of targeted therapeutic strategies for patients with those mutations, as well as in the identification of molecular
Two of America’s most highly respected mesothelioma professionals have been named to new positions at the prestigious International Mesothelioma Interest Group (iMig). Joseph Friedberg, MD, FACS, and Melissa Culligan, RN, BSN, MSc, PhD candidate will bring the expertise that they deploy at Temple Health, the Lewis Katz School of Medicine at Temple University, and Fox
Dr. Bruce E. Johnson is a world-renowned lung cancer physician-scientist. As leader of the Lung Cancer Program for the Dana-Farber/Harvard Cancer Center in Boston, he oversees research that integrates the facilities’ patient populations and science and applies what is discovered to the treatment of patients with lung cancer, mesothelioma, and other thoracic malignancies. Education and